Stem cell shot into ovaries aims to tame perimenopause symptoms

NCT ID NCT07511660

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether injecting special stem-like cells called Muse cells directly into the ovaries can help women aged 28 to 70 who are in perimenopause. The cells may repair tissue, reduce inflammation, and improve hormone balance. Researchers will track safety, hormone levels, and quality of life for 24 months. The goal is to see if this approach can ease symptoms like hot flashes and mood changes without long-term medication.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CELL THERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Stem Solutions

    Monterrey, Nuevo León, 64000, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.